VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

NCRI 2017 | 10-year follow-up: the most effective treatment to ProtecT patients with localized prostate cancer?

An interesting update on the ProtecT trial (NCT02044172) was given by Freddie Hamdy, MBChB, LRCSPEd, LRCSEd, LRCPSGlasg, FRCSEd, MD, FRCSEd(Urol), FRCS, FMedSci, of the University of Oxford, Oxford, UK, at the 2017 National Cancer Research Institute (NCRI) Conference in Liverpool, UK. The ProtecT trial was a randomized Phase III trial that compared three interventions for patients with localized prostate cancer: radical prostatectomy, radiation therapy or active monitoring. Dr Hamdy discusses the study design and presents the findings from the 10-year median follow-up.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter